 Your new post is loading...
The EMA (European Medicines Agency) has released draft guidelines on biosimilars allowing non-EEA comparators to be used in limited circumstances.
A bill passed by the Florida legislature would allow pharmacists to substitute biosimilars for brand-name biologics provided that a number of criteria are met.
PHILADELPHIA, May 23, 2013 /PRNewswire/ -- Echo Therapeutics, Inc. (Nasdaq: ECTE), a company developing its...
Tanzania\'s leading online News Edition (The National Newspaper).
DRI tv is an exciting, new way to learn about the research breakthroughs at the Diabetes Research Institute, including the DRI BioHub.
Can oral insulin succeed where other alternative delivery methods have failed? Dan Stanton, from in-Pharmatechnologist.com assesses its chances.
I am motivated to take care of my diabetes on a daily basis: I feel good when my blood sugars are in-range. I want to be healthy enough to support the people a
Echo Therapeutics, Inc., a company developing its needle-free Symphony CGM System as a non-invasive, wireless, transdermal continuous glucose monitoring system, announced today that the Company's clinical trial of its Symphony CGM System has...
As concerns escalate over the potential risks of glucagon-like peptide-1 (GLP-1)-based therapies, a diabetes journal hosted a point-counterpoint debate between the researchers who have been the leadin...
JERUSALEM, May 17, 2013 /PRNewswire/ --Oramed Pharmaceuticals Inc. (NASDAQCM: ORMP) (http://www.oramed.com), a...
|
Disney has gotten a lot of backlash from the Celiac community for standing up for what we believe in, standing up for what we think is right, and standing up for our kids sakes. If you haven’t heard...
Researchers are launching a large-scale comparative effectiveness trial that will help determine which of the top type 2 diabetes drugs are best for glycemic control.
In this study, using high-throughput sequencing techniques, scientists sought to identify new variants, including rare and potentially high risk ones, in 25 previously identified risk genes in a sample of nearly 42,000 individuals.
Abbott has received EU approval for its new Architect Hemoglobin A1c (HbA1c) assay, a simple blood test designed to aid the diagnosis and monitoring of diabetes.
In 1988, I became extremely ill. I had many tests, saw many doctors and was given various medicines. Some caused allergic reactions. Through it all, I remained sick — and actually became worse.
The FDA says that blood glucose meters haven't advanced in accuracy, even though they have advanced in technology.
I especially loved discovering new diabetes blogs and catching up on blogs I haven't visited in a while.
What a day for Celiac Awareness! The web is all a buzz with Gluten Dude's latest post about a Disney television show plot line where a gluten free character is bullied, mocked and, in my opinion, ...
The American Journal of Medicine, Volume null, Issue null, Pages null, null, Authors:Elizabeth A. Penner, BS; Hannah Buettner, BA; Murray A. Mittleman, MD, DrPH
|